Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00766298 · ClinicalTrials.gov registry record · NA

Skeletal Muscle Lipid and Insulin Resistance: Effects of Physical Activity and Weight Loss

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
102
Enrollment target

NCT00766298 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 102 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00766298, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
102 participants
Enrollment target

Study Summary

102 late- life adults at risk for developing type 2 diabetes mellitus, will be randomized to one of three interventions designed to improve insulin sensitivity thereby potentially preventing future progression of type 2 diabetes. The investigators predict that insulin sensitivity will improve equally following either weight loss or exercise, while there will be additive effects from combined intervention. The investigators hypothesize that weight loss will decrease intermuscular adipose tissue, intramyocellular lipid, and visceral abdominal adipose tissue.

Interventions

  • BEHAVIORAL Exercise
  • BEHAVIORAL Weight Loss
  • BEHAVIORAL Exercise and weight loss

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2004-06
Est. Completion 2011-08
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT00766298

The ClinicalTrials.gov registry entry for NCT00766298 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Exercise is the first listed.

NCT00766298 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00766298 about?

NCT00766298 is a clinical study titled "Skeletal Muscle Lipid and Insulin Resistance: Effects of Physical Activity and Weight Loss". 102 late- life adults at risk for developing type 2 diabetes mellitus, will be randomized to one of three interventions designed to improve insulin sensitivity thereby potentially preventing future progression of type 2 diabetes. The investigators predict that insulin sensitivity will improve equall...

What is the current status of trial NCT00766298?

This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2004-06. Estimated completion is 2011-08.

What interventions are being tested in trial NCT00766298?

The interventions under investigation include: Exercise (BEHAVIORAL), Weight Loss (BEHAVIORAL), Exercise and weight loss (BEHAVIORAL).

Who is sponsoring clinical trial NCT00766298?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.